Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Aspirin in Acute Coronary Syndrome
NCT00910065Phase 3Completed
- Sponsor
- Bayer
- Start
- Mar 2011
- Primary completion
- Apr 2014
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of aspirin in acute coronary syndrome (ACS), sponsored by Bayer. Started Mar 2011; status: completed.
02
Drugs
aspirin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00910065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910065.